Home » Archive

Marketwire, News, Syndication »

Bio-Matrix Scientific Group, Inc. Hires President for Its Regen BioPharma Subsidiary

Posted by Mary Canady May 8th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 8, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today that J. Christopher Mizer has joined the Company as President and Chief Operating Officer of its Regen BioPharma subsidiar…

More...

Marketwire, News, Syndication »

Ardea Biosciences Announces First Quarter 2012 Financial Results

Posted by Mary Canady May 7th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 7, 2012) – Ardea Biosciences, Inc. (NASDAQ: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, today announced first quarter 2012 financial…

More...

Marketwire, News, Syndication »

Bio-Matrix Subsidiary "First in Class" Approach to Stem Cell Medicine

Posted by Mary Canady May 3rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 3, 2012) – Regen BioPharma (Regen), Inc. a newly-formed subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN), unveiled today its operational plan for its “Super-Incubator” stem cell compan…

More...

Marketwire, News, Syndication »

Bio-Matrix Subsidiary "First in Class" Approach to Stem Cell Medicine

Posted by Mary Canady May 3rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 3, 2012) – Regen BioPharma (Regen), Inc. a newly-formed subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN), unveiled today its operational plan for its “Super-Incubator” stem cell compan…

More...

Marketwire, News, Syndication »

Bio-Matrix Subsidiary "First in Class" Approach to Stem Cell Medicine

Posted by Mary Canady May 3rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 3, 2012) – Regen BioPharma (Regen), Inc. a newly-formed subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN), unveiled today its operational plan for its “Super-Incubator” stem cell compan…

More...

Marketwire, News, Syndication »

Senomyx Announces Corporate Update and First Quarter 2012 Financial Results

Posted by Mary Canady May 3rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 3, 2012) – Senomyx, Inc. (NASDAQ: SNMX)
Recent Highlights Include:

Firmenich exercises option to extend R&D funding for the Sweet Taste Program through July 2013

Mar…

More...

Marketwire, News, Syndication »

Senomyx Announces Corporate Update and First Quarter 2012 Financial Results

Posted by Mary Canady May 3rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 3, 2012) – Senomyx, Inc. (NASDAQ: SNMX)
Recent Highlights Include:

Firmenich exercises option to extend R&D funding for the Sweet Taste Program through July 2013

Mar…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary — Regen BioPharma Inc., Secures $20,000,000 in Institutional Funding

Posted by Mary Canady April 30th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 30, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today it has formed a new subsidiary, Regen BioPharma, Inc. Regen BioPharma has developed a vertically-integrated structure for…

More...

Marketwire, News, Syndication »

Cytori to Webcast First Quarter Financial Results May 9

Posted by Mary Canady April 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 27, 2012) – Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its first quarter financial results and business update on Wednesday, May 9, 2012 at 5:00 PM Eastern Time.
The dial-in informatio…

More...

Marketwire, News, Syndication »

Quidel Reports First Quarter 2012 Financial Results

Posted by Mary Canady April 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Apr 25, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today financial results for the first quarter ended March 31, 2012…

More...